Description
PRINCIPIO ACTIVO: DIGOXINA
no mayor a 30 °C
Tratamiento de glioblastoma multiforme
OPDIVO® 100 mg / 10 mL es un medicamento de uso intravenoso que contiene Nivolumab
Información del fabricante según registro sanitario
CRA HUGGIES SUPREM CORP FPUR200ML LISADO BACTERIANO LIOFILIZADO PRINCIPIO ACTIVO: DIGOXINA200 ML Crema Envase
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
